Found: 9
Select item for more details and to access through your institution.
Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 5, p. 1993, doi. 10.1007/s00432-022-04133-8
- By:
- Publication type:
- Article
Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 4, p. 1425, doi. 10.1007/s00432-022-04008-y
- By:
- Publication type:
- Article
BRF2 is mediated by microRNA-409-3p and promotes invasion and metastasis of HCC through the Wnt/β-catenin pathway.
- Published in:
- Cancer Cell International, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12935-023-02893-y
- By:
- Publication type:
- Article
The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.872353
- By:
- Publication type:
- Article
The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.827788
- By:
- Publication type:
- Article
Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1633, doi. 10.1007/s00262-021-03103-2
- By:
- Publication type:
- Article
Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 7, p. 1, doi. 10.1038/s41419-023-05919-5
- By:
- Publication type:
- Article
Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway.
- Published in:
- Cancer Cell International, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12935-023-03034-1
- By:
- Publication type:
- Article